Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

scientific article

Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.NEO.7900080
P932PMC publication ID1507572
P698PubMed publication ID10935508
P5875ResearchGate publication ID12384192

P50authorMing-Sound TsaoQ47492209
P2093author name stringS Yi
P2860cites workMolecular cloning and expression of human hepatocyte growth factorQ24305558
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductQ24310794
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factorQ24555664
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinaseQ28286701
Vascular endothelial growth factor is a secreted angiogenic mitogenQ28646475
Improved retroviral vectors for gene transfer and expressionQ29614384
Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processingQ33263389
Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movementQ34294357
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulationQ35277738
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factorQ35961109
Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenograftsQ35975907
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.Q36136355
Scatter factor induces blood vessel formation in vivoQ36141804
Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cellsQ36223889
Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cellsQ36236279
Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell linesQ36292961
Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis networkQ36557528
NCI-Navy Medical Oncology Branch cell line data baseQ36819549
Evidence for the identity of human scatter factor and human hepatocyte growth factorQ37574028
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activityQ38293448
Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factorQ38324229
Packaging system for rapid production of murine leukemia virus vectors with variable tropismQ40067097
Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interactionQ40560399
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cellsQ40959364
Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytesQ40987654
Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinomaQ40994798
Decreased fibronectin expression in Met/HGF-mediated tumorigenesisQ41004407
Emerging multipotent aspects of hepatocyte growth factorQ41066829
Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactionsQ41079250
Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasisQ41188806
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growthQ41596252
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factorQ41656206
Growth Factor–dependent Activation of αvβ3 Integrin in Normal Epithelial Cells: Implications for Tumor InvasionQ42796734
Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells.Q44115873
Up-regulation of Vascular Endothelial Growth Factor Induced by Hepatocyte Growth Factor/Scatter Factor Stimulation in Human Glioma CellsQ47680471
Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancersQ47706538
The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).Q47767769
Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivoQ48744988
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cellsQ57272714
Gradation of carcinogen-induced capacity for anchorage-independent growth in cultured rat liver epithelial cellsQ57272762
Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markersQ71478326
Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicityQ72306296
Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancerQ73023180
Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomasQ73027878
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude miceQ73273511
P433issue3
P921main subjectadenocarcinomaQ356033
P304page(s)226-234
P577publication date2000-05-01
P1433published inNeoplasiaQ2962042
P1476titleActivation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line
P478volume2

Reverse relations

cites work (P2860)
Q40714043A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line
Q39029873Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice
Q54949177Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer.
Q26751332Biomarker development in MET-targeted therapy
Q35041171C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis
Q40710285CD44 stimulation by fragmented hyaluronic acid induces upregulation and tyrosine phosphorylation of c-Met receptor protein in human chondrosarcoma cells
Q35201636Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression
Q30492361Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells
Q40706645Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival
Q90465717Correlation between Bax gene polymorphisms and esophagus cancer
Q38930336Diagnosis and Molecular Classification of Lung Cancer
Q91798036Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
Q44737495Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
Q40464303Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
Q36660673MET As a Possible Target for Non–Small-Cell Lung Cancer
Q37232416MET as a target for treatment of chest tumors
Q89603062MET targeting: time for a rematch
Q49888000Mechanisms of receptor tyrosine kinase activation in cancer
Q36828371Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy
Q38869428Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors
Q26860232Prognostic value of c-Met in colorectal cancer: a meta-analysis
Q24609682The MET axis as a therapeutic target
Q39274990The c-Met receptor: Implication for targeted therapies in colorectal cancer
Q35563524The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
Q37962905c-MET as a potential therapeutic target and biomarker in cancer
Q36731520c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy